Louis P. Kassa III, MPA, became president of the nonprofit Pennsylvania Biotechnology Center (PABC) on July 1, 2022. He also is now interim chief executive officer of the PABC, Hepatitis B Foundation and Baruch S. Blumberg Institute. Kassa, who joined the organizations in 2014, succeeded Timothy M. Block, PhD, founding president of the PABC. Dr. Block has become executive chair of the Hepatitis B Foundation Board of Directors, which governs the PABC and Blumberg Institute. Please read more here.
The nonprofit Pennsylvania Biotechnology Center (PABC), one of the nation’s most successful life sciences incubators, generated $7.3 billion in economic activity in the region during 2016 to 2021, according to a new study commissioned by the PABC’s management. During those six years, the Doylestown-area biotech facility produced 1,135 new jobs. Of those, 500 were jobs with PABC-member companies and 635 were jobs in Pennsylvania, excluding Bucks County. Please read more here.
The Pennsylvania Biotechnology Center (PABC) generated $7.3 billion in economic activity in the region during 2016 to 2021, according to a new study commissioned by the PABC’s management. Please read more here.
The nonprofit Pennsylvania Biotechnology Center (PABC), one of the nation’s most successful life sciences incubators, is proud to announce that IGM Biosciences Inc. (Nasdaq: IGMS) of Mountain View, Calif., is one of the center’s newest member companies and will be expanding its R&D footprint at the PABC’s Doylestown campus. Please read more here.
Senator Santarsiero Secures $1.57 million for Biotech Investment in Bucks County
State Senator Steve Santarsiero (D-10) announced today that he has secured $1,577,500 in state funds from the Redevelopment Assistance Capital Program (RACP) for the Pennsylvania Biotechnology Center, the life sciences incubator in Buckingham Township. “I’d like to thank Governor Wolf for supporting my request to dedicate RACP funds for the continued growth and expansion of the Pennsylvania Biotechnology Center,” said Sen. Santarsiero. Please read more here.
PABC announces new collaboration and $10 million investment pledge from Daiichi Sankyo Inc.
The PABC announced on March 31 a new collaboration that includes a pledge by Daiichi Sankyo to become an investor in the fund managed by Hatch Biofund Management LLC. An investment of $10 million has been committed by Daiichi Sankyo to Hatch Biofund 1, which was created by the Baruch S. Blumberg Institute as a companion to their Incubator and BioAccelerator. Please read more here.
Doylestown, Nov. 19, 2020 – Louis P. Kassa, MPA, executive vice president and chief operating officer of the Pennsylvania Biotechnology Center, has been named one of “The 10 Best COOs of 2020” by Industry Era, a global technology media outlet. The list includes COOs from a wide variety of organizations worldwide.
Since joining the Pennsylvania Biotechnology Center (PABC) in 2014, Kassa has led the PABC to become one of the nation’s leading life sciences incubators, according to a report by the International Business Innovation Association.
The PABC is a nonprofit that offers state-of-the-art laboratory and office space to early stage biotech companies, as well as the Hepatitis B Foundation and Blumberg Institute. With more than 70 member companies, the center is home to 41 small to mid-size science, research and biotechnology companies. The PABC has been at full capacity for the past seven years and there is a waiting list of companies that want to locate in the PABC, Kassa said. “We have a very specific ecosystem and services platform that helps entrepreneurs find a path for success,” Kassa said.Learn More